Viewing Study NCT02004093


Ignite Creation Date: 2025-12-25 @ 1:24 AM
Ignite Modification Date: 2025-12-27 @ 3:58 AM
Study NCT ID: NCT02004093
Status: COMPLETED
Last Update Posted: 2014-12-04
First Post: 2013-12-03
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer
Sponsor: Hoffmann-La Roche
Organization: